Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers
Status:
Completed
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the
pharmacokinetics of three different single doses activated recombinant human factor VII in
Caucasian and Japanese healthy subjects.